- Scheme Category:
- >
NAV: ₹ ↑ 0.53%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Mirae Asset Healthcare Fund Direct Growth and its peers as on 11 August, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirae Asset Healthcare Fund Direct Growth | 21.56% | 0.53% | 0.89% | 3.71% | 9.68% | 22.35% | 23.51% | 16.31% | 26.13% | - |
| SBI Crisil - IBX SDL Index - June 2034 Index Fund - Direct Plan - Growth | - | -0.17% | 0.11% | - | - | - | - | - | - | - |
| HDFC Nifty Auto Index Fund- Direct Plan- Growth Option | - | -0.54% | 1.58% | 10% | - | - | - | - | - | - |
| Kotak Money Market Fund - (Growth) - Direct | 4.08% | 0.02% | 0.18% | 0.65% | 1.92% | 6.51% | 7.42% | 6.65% | 6.29% | 6.66% |
| Kotak Savings Fund-Growth - Direct | 4.01% | 0.03% | 0.16% | 0.64% | 1.81% | 6.5% | 7.26% | 6.52% | 6.28% | 6.73% |
| Kotak Bond Short Term Plan-(Growth) - Direct | 3.61% | -0.02% | 0.26% | 0.56% | 2.29% | 5.84% | 7.68% | 6.65% | 7.1% | 7.39% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | 8.32% | 77.37% | 27.95% | -10.87% | 36.86% | 41.36% | -2.65% |
Discrete returns (monthly)
| Month | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 1.89% | -0.38% | -0.71% | -5.19% | 7.4% | -3.5% | 6.96% | 3.31% | 5.37% | 5.1% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.92% | 0.01% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.07% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.20% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.93% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 6.94% |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 6.88% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.15% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 5.06% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.32% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.31% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 3.73% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.56% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.44% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.37% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 3.32% |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 3.26% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.25% |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 3.03% |
| Onesource Specialty Pharma Ltd. | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 2.91% |
| Eris Lifesciences Ltd. | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 2.67% |
| Dr. Lal Path labs Ltd. | LALPATHLAB (INE600L01024) | Healthcare Services | 1.95% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.88% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.67% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.27% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.25% |
| Narayana Hrudayalaya Ltd. | NH (INE410P01011) | Healthcare Services | 1.17% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 1.11% |
| Rubicon Research Ltd. | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 0.85% |
| Sagility Ltd. | SAGILITY (INE0W2G01015) | IT - Services | 0.54% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 0.49% |
| Sudeep Pharma Ltd. | SUDEEPPHRM (INE0QPI01025) | Pharmaceuticals & Biotechnology | 0.44% |
| Deepak Nitrite Ltd. | DEEPAKNTR (INE288B01029) | Chemicals & Petrochemicals | 0.43% |
| Neogen Chemicals Ltd. | NEOGEN (INE136S01016) | Chemicals & Petrochemicals | 0.42% |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 0.09% |
Debt
| Name | Rating | Weight % |
|---|---|---|
| Mirae Asset Liquid Fund-Direct Plan-Growth | 0.01% |
Portfolio data is as on date 31 March, 2026
NAV history
Mirae Asset Healthcare Fund Direct Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 11 August, 2026 | 51.966 | 0.53% |
| 10 August, 2026 | 51.690 | -0.03% |
| 7 August, 2026 | 51.708 | 0.2% |
| 6 August, 2026 | 51.607 | 0.08% |
| 5 August, 2026 | 51.568 | 0.12% |
| 4 August, 2026 | 51.507 | -0.27% |
| 3 August, 2026 | 51.648 | 0.22% |
| 31 July, 2026 | 51.537 | 0.42% |
| 30 July, 2026 | 51.320 | -0.33% |
| 29 July, 2026 | 51.489 | 1.38% |
| 28 July, 2026 | 50.789 | 0.14% |
| 27 July, 2026 | 50.717 | 1.57% |
| 24 July, 2026 | 49.932 | -0.14% |
| 23 July, 2026 | 50.003 | -0.54% |
| 22 July, 2026 | 50.273 | -1.13% |
| 21 July, 2026 | 50.847 | 0.21% |
| 20 July, 2026 | 50.741 | 1.08% |
| 17 July, 2026 | 50.198 | -0.99% |
| 16 July, 2026 | 50.701 | -0.1% |
| 15 July, 2026 | 50.750 | 0.35% |
| 14 July, 2026 | 50.571 | 0.73% |
| 13 July, 2026 | 50.206 | 0.2% |
| 10 July, 2026 | 50.107 | 0.28% |
| 9 July, 2026 | 49.965 | 1.12% |
| 8 July, 2026 | 49.413 | -1.04% |
| 7 July, 2026 | 49.932 | -0.6% |
| 6 July, 2026 | 50.233 | 0.24% |
| 3 July, 2026 | 50.111 | 1.35% |
| 2 July, 2026 | 49.443 | 0.83% |
| 1 July, 2026 | 49.038 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 51.966 as on 11 August, 2026.What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are 21.56% as on 11 August, 2026.What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 22.35% as on 11 August, 2026.What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 23.51% as on 11 August, 2026.What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 16.31% as on 11 August, 2026.